TABLE 1

Patient Demographics

DemographicData
Total number of patients42
 1 dose20
 2 doses22
Primary malignancy
 Neuroblastoma32
 Medulloblastoma2
 Sarcoma3
 Ependymoma1
 Rhabdoid tumor1
 Melanoma1
 Chordoma1
 Choroid plexus tumor1
Age range3 mo–42 y
Sex
 Male26
 Female16
  • Data are n, except for age.